STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #43 by analyst upside · 2026-06-27
ALUR
Allurion Technologies Inc
Healthcare · Market Cap $83M · P/E 0x
ANALYST PRICE TARGET
+1386.5%
implied upside to consensus target
Current Price $5.55
Consensus Target $82.5
Bull Target $120.0
Bear Target $45.0
Analysts Covering 2
ANALYST CONSENSUS - UNDERPERFORM
Strong Buy
0
Buy
0
Hold
1
Sell
1
52-Week Low $0.55
52-Week High $49.95
YTD Return -86.5%
FUNDAMENTALS
Market Cap $83M
P/E Ratio (TTM) N/A
Forward P/E -4.5x
EPS (TTM) $-3.96
PEG Ratio N/A
Dividend Yield N/A
Revenue (TTM) $13M
Profit Margin -264.7%
52-WEEK RANGE
52-Week Low $0.55
52-Week High $49.95
Current Price $5.55
Bear Target $45.0
Bull Target $120.0
● Now $5.55 ● Target $82.5
TRADING DATA
Avg Volume 4K
YTD Return -86.5%
Analyst Count 2
Consensus Underperform
Upside to Target +1386.5%
Last Updated 2026-06-27

ANALYST SUMMARY

Allurion Technologies Inc (ALUR) is currently trading at $5.55 with a Wall Street consensus price target of $82.5, implying potential upside of 1386.5% over the next 12 months. 2 analysts currently cover ALUR, with a consensus rating of Underperform - 0% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $120.0, while the most cautious has a target of $45.0.

ALUR operates in the Healthcare sector with a market capitalisation of $83M. The stock is down 86.5% year-to-date and is currently trading near the lower end of its 52-week range of $0.55 – $49.95.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for ALUR, with each firm's 90-day track record across all stocks we track. See full firm rankings →

Chardan Capital ↑ Upgrade
Neutral → Buy 2026-02-24 33% win rate (6 calls)
Chardan Capital — Reiterated
Neutral → Neutral 2025-11-20 33% win rate (6 calls)
Chardan Capital — Reiterated
Neutral → Neutral 2025-03-27 33% win rate (6 calls)
Roth MKM reit
Buy → Buy 2025-03-21 25% win rate (12 calls)
Chardan Capital — Reiterated
Neutral → Neutral 2025-03-21 33% win rate (6 calls)
Chardan Capital ↓ Downgrade
Buy → Neutral 2024-11-14 33% win rate (6 calls)
TD Cowen ● Initiated
Buy 2024-10-02 Building track record
Roth MKM ● Initiated
Buy 2024-09-06 25% win rate (12 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
10
out of 100
Coverage depth
8/30
Consensus clarity
0/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →